# Use of nicotine products and tobacco cessation in Swiss primary care: Cross-sectional data from the Sentinella network

**Authors:** Marc Huguenot, Christina Hempel-Bruder, Ines Habfast-Robertson, Eva Guettinger, Isabelle Jacot-Sadowski, Julian Jakob, Reto Auer, Kevin Selby

PMC · DOI: 10.1016/j.pmedr.2025.103013 · Preventive Medicine Reports · 2025-02-17

## TL;DR

This study examines nicotine product use and smoking cessation efforts in Swiss primary care, finding that many patients use tobacco and few receive adequate support to quit.

## Contribution

The study provides current cross-sectional data on nicotine use and cessation practices in Swiss primary care settings.

## Key findings

- One in five patients in primary care use nicotine products, primarily cigarettes.
- Over half of patients planning to quit smoking do so without any medical aid.
- Vaping is rarely recommended as a quit aid due to physician concerns about its safety.

## Abstract

We aimed to characterize current tobacco and nicotine product use and tobacco cessation efforts in Swiss primary care, including the prescription of medications and recommendation of vapes to quit smoking.

Cross-sectional study from pediatricians and primary care physicians (PCPs) in the Swiss Sentinella network (practice-based network to monitor infectious diseases). PCPs collected data from 30 consecutive patients ≥12 years of age between September and December 2021. Patient data included age, gender, nicotine products use, plans to quit, and time discussing smoking cessation. PCP data were their use of medications, follow-up appointments, and vapes for quitting smoking.

Eighty-nine of 168 PCPs participated (53 %) and collected data on 2438 patients, of whom 523 (21,5 %) used a nicotine product within seven days, of whom 88 % smoked cigarettes. Among the 106 (20 %) who planned to quit smoking, 16 (15 %) planned to use nicotine replacement therapy, nine (9 %) varenicline, six (6 %) vapes, five (5 %) bupropion, and 57 no treatment (54 %). Moreover, 236 (46 %) of 523 patients using nicotine products received one to five minutes of cessation advice, 80 (16 %) six to ten minutes, and 17 (3 %) >10 min. Half of PCPs offered follow-up and medications to ≥50 % of patients planning to quit, while 52 % never recommended vapes.

The use of nicotine products remains common among primary care patients, the majority of whom smoke cigarettes. Nicotine products without tobacco remain relatively rare. After the consultation, one in five patients using nicotine products planned to quit, the majority without any aid.

•One in five patients seen in primary care use nicotine products, mostly cigarettes.•One in five patients using nicotine products plan to quit within the next three months.•After seeing their primary care physician, over half plan to quit without help.•Vapes are rarely used as quit aids, as most physicians perceive them as harmful.

One in five patients seen in primary care use nicotine products, mostly cigarettes.

One in five patients using nicotine products plan to quit within the next three months.

After seeing their primary care physician, over half plan to quit without help.

Vapes are rarely used as quit aids, as most physicians perceive them as harmful.

## Full-text entities

- **Diseases:** infectious diseases (MESH:D003141)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11908592/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11908592/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC11908592/full.md

---
Source: https://tomesphere.com/paper/PMC11908592